Annals of Epidemiology
Volume 20, Issue 2 , Pages 108-121 , February 2010

Glutathione S–Transferase M1 Polymorphism and Sporadic Colorectal Cancer Risk: An Updating Meta-Analysis and HuGE Review of 36 Case-Control Studies

  • Yong Gao, PhD

      Affiliations

    • Department of Urology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
  • ,
  • Yunfei Cao, PhD

      Affiliations

    • Department of Coloproctological Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
  • ,
  • Aihua Tan, PhD

      Affiliations

    • Department of Coloproctological Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
  • ,
  • Cun Liao, PhD

      Affiliations

    • Department of Coloproctological Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
  • ,
  • Zengnan Mo, PhD

      Affiliations

    • Department of Urology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
  • ,
  • Feng Gao, PhD

      Affiliations

    • Department of Coloproctological Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
    • Corresponding Author InformationAddress correspondence to: Feng Gao, Department of Colorectal and Anal Surgery, First Affiliated Hospital, Guangxi Medical University, Guangxi, China. Tel.: (86)771-5356529; Fax: (86)771-5356529.

Received 8 April 2009 ,Accepted 21 October 2009.

References 

  1. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600
  2. Ketterer BA. bird's eye view of the glutathione transferase field. Chem Biol Interact. 2001;138:27–42
  3. Mannervik B, Danielson UH. Glutathione transferases–structure and catalytic activity. CRC Crit Rev Biochem. 1988;23:283–337
  4. Pickett CB, Lu AY. Glutathione S-transferases: gene structure, regulation, and biological function. Annu Rev Biochem. 1989;58:743–764
  5. Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J. 2001;360:1–16
  6. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci. 1999;49:156–164
  7. Armstrong RN. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol. 1997;10:2–18
  8. Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, et al. Metabolic polymorphisms and susceptibility to cancer. Lyon: International Agency for Research on Cancer; 1999;
  9. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res. 2000;463:247–283
  10. Hecht S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91:1194–1210
  11. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6:733–743
  12. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, et al. The human glutathione S-transferases: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis. 1991;12:25–28
  13. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 1993;14:1821–1824
  14. Zhong S, Howie A, Ketterer B, Taylor J, Hayes JD, Beckett GJ, et al. Glutathione S-transferases mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis. 1991;12:1533–1537
  15. Hengstler J, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res. 1998;154:47–85
  16. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000;151:7–32
  17. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2002;2005(55):74–108
  18. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No 5, version 2.0. Lyon: IARC Press; 2004;
  19. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2005 Incidence and Mortality Web-based Report. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2009;
  20. Bray F, Atkin W. International cancer patterns in men: geographical and temporal variations in cancer risk and the role of gender. The Journal of Men's Health & Gender. 2004;1:38–46
  21. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592
  22. Potter JD. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA. 1992;268:1573–1577
  23. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15:499–545
  24. Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol. 2000;10:349–360
  25. Solomon E. Colorectal cancer genes. Nature. 1990;343:412–414
  26. Muller HH, Heinimann K, Dobbie Z. Genetics of hereditary colon cancer – a basis for prevention?. Eur J Cancer. 2000;36:1215–1223
  27. Ye Z, Parry JM. A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit. 2003;9:SR83–91
  28. Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol. 2005;11:331–335
  29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  30. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet. 2005;50:267–275
  31. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101
  32. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  33. Schlesselman JJ. Case-control studies, design, conduct, analysis. Oxford: Oxford University Press; 1982;
  34. Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer. 2004;91:344–354
  35. Holley SL, Rajagopal R, Hoban PR, Deakin M, Fawole AS, Elder JB, et al. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer. Int J Oncol. 2006;28:231–236
  36. Lamberti C, Jungck M, Laarmann M, Knapp M, Caspari R, Friedl W, et al. Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis. Pharmacogenetics. 2002;12:49–54
  37. Berkhout M, Roelofs HM, te Morsche RH, Dekker E, van Krieken JH, Nagengast FM, et al. Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis. Br J Surg. 2008;95:499–505
  38. Shin JH, Ku JL, Shin KH, Shin YK, Kanq SB, Park JG. Glutathione S-transferase M1 associated with cancer occurrence in Korean HNPCC families carrying the hMLH1/hMSH2 mutation. Oncol Rep. 2003;10:483–486
  39. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15:2307–2310
  40. Fan C, Jin M, Chen K, Zhang Y, Zhang S, Liu B. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer. 2007;7:115
  41. Yoshioka M, Katoh T, Nakano M, Takasawa S, Nagata N, Itoh H. Glutathione S-transferase (GST) M1, T1, P1, N-acetyltransferase (NAT) 1 and 2 genetic polymorphisms and susceptibility to colorectal cancer. J UOEH. 1999;21:133–147
  42. Kampman E, Slattery ML, Bigler J, Leppert M, Samowitz W, Caan BJ, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case–control study. Cancer Epidemiol Biomarkers Prev. 1999;8:15–24
  43. Kiss I, Sandor J, Pajkos G, Bogner B, Hegedus G, Ember I. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione–S-transferase M1 enzymes. Anticancer Res. 2000;20:519–522
  44. Slattery ML, Potter JD, Ma KN, Caan BJ, Leppert M, Samowitz W. Western diet, family history of colorectal cancer, NAT2, GSTM–1 and risk of colon cancer. Cancer Causes Control. 2000;11:1–8
  45. Slattery ML, Kampman E, Samowitz W, Caan BJ, Potter JD. Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer. 2000;87:728–733
  46. Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC . Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis. 2002;23:2055–2061
  47. Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol. 2005;11:1473–1480
  48. Chenevix-Trench G, Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 1995;16:1655–1657
  49. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–1859
  50. Deakin M, Elder J, Hendrickse C, Peckham D, Wild N, Leopard P, et al. Glutathione S–transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881–884
  51. Guo JY, Wan DS, Zeng RP, Zhang Q. The polymorphism of GSTM1, mutagen sensitivity in colon cancer and healthy control. Mutat Res. 1996;372:17–22
  52. Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K, Hunter DJ. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 1998;7:1001–1005
  53. Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci. 1998;23:140–142
  54. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1998;7:1079–1084
  55. Abdel-Rahman SZ, Soliman AS, Bondy ML, Wu X, El-Badawy SA, Mahgoub KG, et al. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett. 1999;142:97–104
  56. Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:289–292
  57. Zhang H, Ahmadi A, Arbman G, Zdolsek J, Carstensen J, Nordenskjold B, et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer. 1999;84:135–138
  58. Gawronska-Szklarz B, Lubinski J, Kladny J, Kurzawski G, Bielicki D, Wojcicki M, et al. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Exp Toxicol Pathol. 1999;51:321–325
  59. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol. 2001;16:631–635
  60. Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA, et al. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis. 2001;22:1053–1060
  61. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21–26
  62. Tiemersma EW, Kampman E, Bueno de Mesquita HB, Bunschoten A, van Schothorst EM, Kok FJ, et al. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control. 2002;13:383–393
  63. Ye Z, Parry JM. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen. 2002;22:385–392
  64. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis. 2002;23:1839–1849
  65. Zhu Y, Deng C, Zhang Y, Zhou X, He X. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi. 2002;41:538–540
  66. Laso N, Lafuente MJ, Mas S, Trias M, Ascaso C, Molina R, et al. Glutathione S-transferase (GSTM1 and GSTT1)–dependent risk for colorectal cancer. Anticancer Res. 2002;22:3399–3403
  67. Sgambato A, Campisi B, Zupa A, Bochicchio A, Romano G, Tartarone A, et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res. 2002;22:3647–3652
  68. Nascimento H, Coy CS, Teori MT, Boin IF, Goes JR, Costa FF, et al. Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum. 2003;46:510–515
  69. Slattery ML, Edwards S, Curtin K, Schaffer D, Neuhausen S. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:882–889
  70. van der Hel OL, Bueno de Mesquita HB, Roest M, Schaffer D, Neuhausen S. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:681–682
  71. Kiss I, Nemeth A, Bogner B, Pajkos G, Orsos Z, Sandor J, et al. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res. 2004;24:3965–3970
  72. van der Logt EM, Bergevoet SM, Roelofs HM, van Hooijdonk Z, te Morsche RH, Wobbes T, et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis. 2004;25:2407–2415
  73. Chen K, Jiang QT, Ma XY, Yao KY, Leng SG, Yu WP, et al. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study. Zhonghua Zhong Liu Za Zhi. 2004;26:645–648
  74. Ates NA, Tamer L, Ates C, Ercan B, Elipek T, Ocal K, et al. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet. 2005;43:149–163
  75. Huang K, Sandler RS, Millikan RC, Schroeder JC, North KE, Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a non-hospital case-control study in North Carolina (United States). Cancer Causes Control. 2006;17:385–394
  76. Little J, Sharp L, Masson LF, Brockton NT, Cotton SC, Haites NE, et al. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer. 2006;119:2155–2164
  77. Martinez C, Martin F, Fernandez JM, Garcia-Martin E, Sastre J, Diaz-Rubio M, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–718
  78. Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, Yu MC. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis. 2006;27:2475–2482
  79. Skjelbred CF, Saebo M, Hjartaker A, Grotmol T, Hansteen IL, Tveit KM, et al. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer. 2007;7:228
  80. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci. 2007;14:183–193
  81. Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, Hayamizu S, et al. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev. 2007;8:438–444
  82. Csejtei A, Tibold A, Varga Z, Koltai K, Ember A, Orsos Z, et al. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer. Anticancer Res. 2008;28:1917–1922
  83. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999;28:1–9
  84. Martinez-Lara E, Siles E, Hernandez R, Cañuelo AR, Luisa del Moral M, Jiménez A, et al. Glutathione S-transferase isoenzymatic response to aging in rat cerebral cortex and cerebellum. Neurobiol Aging. 2003;24:501–509

PII: S1047-2797(09)00340-8

doi: 10.1016/j.annepidem.2009.10.003

Annals of Epidemiology
Volume 20, Issue 2 , Pages 108-121 , February 2010